1Mayauchi T,Brown RS,Grossman HB,et al.Correlation between visulization of primary renal cancer by FDG-PET and histopathological findings[].The Journal of Nuclear Medicine.1996
2Hoh CK,Rosen PJ,Belldegrun A,et al.Quantitative and whole body FDG PET in the evaluation of suramin therapy in patents with metastatic prostate cancer[].J Nucl Med suppl.1996
3Bachor R,Kotzerke J,Gottfried H,et al.Positron emission tomography in diagnosis of renal cell carcinoma[].Urology.1996
4Hoh CK,Seltzer MA,Franklin J,et al.Positron emission tomography in urological oncology[].Journal d Urologie.1998
5Franklin J,Hoh C,Gitlitz B,et al.Positron emission tomography (PET) scan for imaging of advanced renal cell carcinoma (RCC)[].Journal d Urologie.1996
6Oyama N,Akino H,Suzuki Y,et al.The increased accumulation of [ 18F ] fluorodeoxyglucose in untreated prostate cancer[].Japanese Journal of Clinical Oncology.1999
7Hams W,Bares R,Kamps H,et al.Therapy control of metastatic testicular carcinoma with F18-DOG PET[].The Journal of Nuclear Medicine.1995
